1. FASEB J. 2025 Feb 28;39(4):e70377. doi: 10.1096/fj.202402677RR. Dolutegravir induces endoplasmic reticulum stress at the blood-brain barrier. Huang C(1), Qu QR(1), Hoque MT(1), Bendayan R(1). Author information: (1)Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada. Dolutegravir (DTG)-based antiretroviral therapy is the contemporary first-line therapy to treat HIV infection. Despite its efficacy, mounting evidence has ...